Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.06 | €50.33 | 25.643% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.85 | €26.01 | 31.048% |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €102.95 | €184.92 | 79.621% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.70 | €421.61 | 15.921% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |
| Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.37 | €63.93 | 17272.554% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.80 | €20.43 | 73.157% |
| United Therapeutics | 18 | 0 | 3 | 0 | €245.40 | €288.66 | 17.629% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €142.70 | €236.30 | 65.591% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.24 | €196.74 | 41.293% |
| Insmed Inc. | 14 | 1 | 2 | 0 | €24.40 | €43.04 | 76.402% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.22 | €10.00 | 21.655% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| Personalis Inc | 7 | 0 | 2 | 0 | €1.50 | €3.25 | 117.275% |
| Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €69.10 | €100.00 | 44.718% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.40 | €50.00 | 26.904% |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 2 | 0 | €0.98 | €2.78 | 183.400% |
| BeiGene Ltd ADR | 9 | 1 | 2 | 0 | €152.00 | €241.54 | 58.910% |
| G1 Therapeutics | 15 | 1 | 2 | 0 | €4.46 | €10.56 | 136.643% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €11.10 | €21.00 | 89.222% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.60 | €45.98 | 29.157% |
| Teva Pharmaceutical Industries Ltd ADR | 12 | 1 | 2 | 1 | €15.15 | €17.65 | 16.471% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €96.61 | €116.81 | 20.906% |